Friday, February 02, 2024 1:39:11 AM
If you are not reading the companies posts to X you are not up to date. They have apparently decided that is their marketing tool (I'm not thrilled about that, as it requires an account and it pretty crappy site now) and this is where their non quarterly updates are going. I shouldn't have to tell anyone this, but you can't only read the posts you have to read the replies. Do a little DD.
On 1/25 they posted they completed phase 1
Another update and another step that was taken during the fourth quarter #cancertherapy #newgenerationtherapy #genotoxicity #radiogel #isopet #innovations #cancer $RDGL pic.twitter.com/alvoqEDpXS
— Vivos Inc. (@VivosIncUSA) January 25, 2024
Then later that day clarified there were two phases
Two phases of testing, one phase of analysis, we are doing what is required and will update on the progress, stay tuned!
— Vivos Inc. (@VivosIncUSA) January 25, 2024
Follow the thread and you will see they never say when the second phase will occur despite being clearly asked. They just repeat the same story of we will keep you informed.
As I noted before, I believe they either don't know when they can get the second phase of testing done or they know it will take a long time and don't want to tell us.
It is most likely to be the former. Not just anyone can do genotoxicity testing. They have to find the experts that can do the testing and get on that companies calendar. Whatever the reason, taking the approach of avoiding giving an answer to a question any investor would want answered is stupid, diengienious, and detrimental to the investors interests.
Recent RDGL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:28:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM